Navigation Links
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Date:7/29/2009

EXTON, Pa., July 29 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the second quarter ended June 30, 2009.

  • Delivered record $82 million in net product sales including $26 million in net sales of Cinryze(TM) (C1 esterase Inhibitor [human]), of which $2 million was previously classified as deferred revenue;
  • Grew adjusted net income 19 percent to $34 million for the 2009 second quarter compared to prior year period; GAAP net income reached $16 million;
  • Improved working capital to $328 million as of the end of the second quarter of 2009, including cash and cash equivalents of $267 million; and
  • Achieved positive cash flows from operations of $25 million.

Net sales were $81.9 million and $142.1 million for the three and six months ended June 30, 2009, respectively, as compared to $65.4 million and $116.4 million for Vancocin only in the comparative three and six month periods of 2008, respectively. This represents 25 percent growth in the three month period and 22 percent growth for the six month period in net product sales.

The Company is reporting both GAAP net income (loss) and adjusted results for the three and six months ended June 30, 2009. Adjusted net income is GAAP net income excluding (1) non-cash interest expense, (2) amortization related to the acquisition of Lev Pharmaceuticals and Vancocin, and step up in inventory related to purchase accounting arising from the acquisition of Lev Pharmaceuticals, (3) stock compensation expenses, and (4) certain non-recurring events such as the goodwill write off and gain on extinguishment of repurchased bonds. A reconciliation between GAAP and adjusted net inco
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
2. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
3. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
4. ViroPharma to Present at Two May Healthcare Conferences
5. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
6. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
7. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. ViroPharma Provides Update on Vancocin(R)
11. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... 25, 2013 Today, Zane Benefits, Inc. ... . Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution plans and HRAs ... 1, 2013 open enrollment of the Health Insurance Marketplaces ... Marketplaces is "Choice, Competition and Clout for States." ...
(Date:5/25/2013)... Los Angeles, California (PRWEB) May 25, 2013 ... Vogue Magazine titled “Hooked on a Feeling,” nearly 30 million ... the beach to tan despite knowing the health ... a relaxing, seductive and even addictive effect on the brains ... no data included in the article so I can’t say ...
(Date:5/25/2013)... While some will be spending their ... serving our Country, many others will simply enjoy their ... The DUI attorneys at MacGregor & Collins, LLP have ... keep this weekend’s party-goers out of trouble. , According ... more than 950 fatal alcohol-related collisions and 16,000 injuries ...
(Date:5/25/2013)... NYC,NY (PRWEB) May 25, 2013 Dr. ... only non-invasive procedure FDA-approved to lift skin on the neck, ... available at her practice, Medical Aesthetics. , Ultherapy is a ... body’s own natural healing process to lift the skin over ... the first time, to see and then treat the deepest ...
(Date:5/25/2013)... Life science and analytical reagents are ... and create a new substance with the purpose of ... known as biotechnology reagents. Such reagents are significant in ... This market is driven by factors such as expansion ... therapeutics, growth in research and rapid commercialization of such ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Health Insurance Marketplaces 2Health News:Zane Benefits Publishes New Information on the Health Insurance Marketplaces 3Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3
... less effective in deep joint areas, study finds ... of hyaluronic acid is no more effective than a placebo ... , Hyaluronic acid (HA), a substance found in normal joint ... which lubricates and protects joints. The use of HA injections ...
... easier with some advance preparation , , FRIDAY, March 6 (HealthDay ... precious sleep when the clocks shift forward into daylight saving ... that you could lose a lot more if you don,t ... "There are more accidents on the road within two days ...
... United States has intervened in a whistleblower suit filed in ... (CHS) and three of its hospitals in New Mexico: Eastern ... Deming, and Alta Vista Regional Hospital in Las Vegas. ... the False Claims Act (FCA) by knowingly causing to be ...
... a statement of Esta Soler, President, Family Violence Prevention Fund:"Sadly, ... not unique -- women and girls in every community experience ... police report seems to suggest that this was an extremely ... is deeply disturbing. As with all dating and domestic ...
... VIEW, Calif., March 6 Alexza Pharmaceuticals, Inc. (Nasdaq: ... for its fiscal year ended December 31, 2008, on Tuesday, ... markets. The Company will host an investor conference call ... at 4:30 p.m. Eastern Time the same day. A ...
... may affect diaphragm, chest wall to decrease volume, study ... big around the middle can put the squeeze on ... than 120,000 people. , It was already known that ... women and greater than 40 inches for men) was ...
Cached Medicine News:Health News:Hip Osteoarthritis Therapy No Better Than Placebo 2Health News:Spring Forward? Plan Ahead 2Health News:United States Joins Suit Against Community Health Systems Inc. and Three of Its Hospitals in New Mexico 2Health News:Leading Domestic Violence Expert Comments on New Developments in the Rihanna/Chris Brown Case 2Health News:Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009 2Health News:Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009 3Health News:Belly Fat Puts the Pressure on Lungs 2
(Date:5/24/2013)... 24, 2013  BD (Becton, Dickinson and Company) (NYSE: ... today that it will present at the Deutsche Bank 38 ... 2013, at 10:40 a.m. (ET). A live ... corporate website at www.bd.com/investors and will be available ... About BD BD is a leading global medical ...
(Date:5/24/2013)... BEIJING , May 24, 2013 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company has recently learned from a public announcement issued ... a public company listed on Shenzhen Stock Exchange, that ... Chan ("Ms. Chan"), one of the shareholders ...
(Date:5/24/2013)... CITY, England and BOSTON ... leading GPCR drug discovery and development company, is pleased to announce ... as a Consultant to augment the Company,s business development capabilities in ... Mr Usui has more than 15 years of experience in business ... roles at Perlegen Sciences, Inc., Roche Pharma ( Japan ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Bill would remove financial penalties for participating in ... Sept. 16 Four members of the United States Senate introduced ... clinical drug studies without losing their eligibility for public healthcare coverage, ... , The "Improving Access to Clinical Trials Act" ...
... , , BINGHAMTON, ... research, a team of Binghamton University (BU) researchers working with ... ground in the recognition of cryosurgery as a primary treatment ... a Best Practices Statement that recommends cryosurgery of the prostate ...
Cached Medicine Technology:Senate Introduces Bill to Boost Participation in Clinical Trials for Rare Diseases 2Senate Introduces Bill to Boost Participation in Clinical Trials for Rare Diseases 3Binghamton Research Group Develops New Cancer Treatment 2Binghamton Research Group Develops New Cancer Treatment 3Binghamton Research Group Develops New Cancer Treatment 4
... as thread-guide reducing time and trauma in ... is inserted into the nasolacrimal duct and ... it. The probe is then withdrawn leaving ... tubing in place. Canalicular Laceration or Imperforate ...
... prolene as thread-guide reducing time and trauma ... Probe is inserted into the nasolacrimal duct ... through it. The probe is then withdrawn ... silicone tubing in place. Newly coated with ...
For Canalicular Stenosis in Infants. Medical grade silicone. Note: Can also be used in DCR because of its high flexibility. Probe entirely embedded in silicone tubing (non-traumatic). Box of 3, steri...
For proper plug sizing....
Medicine Products: